Inhibitor Therapeutics Market Cap

Inhibitor Therapeutics has a market cap or net worth of $8.08 million as of June 30, 2025. Its market cap has increased by 51.12% in one year.

Market Cap

8.08M

Enterprise Value

3.84M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.04

Market Cap Chart

Since October 29, 1997, Inhibitor Therapeutics's market cap has decreased from 14.08M to 8.08M, a decrease of -42.58%. That is a compound annual growth rate of -1.98%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	8.08M	-21.96%
Dec 31, 2024	10.36M	-34.56%
Dec 28, 2023	15.83M	-57.47%
Dec 28, 2022	37.21M	-34.06%
Dec 30, 2021	56.43M	332.16%
Dec 31, 2020	13.06M	-36.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	781.22M
Elite Pharmaceuticals	759.65M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	449.82M
Glass House Brands	442.61M
Northwest Biotherapeutics	349.23M

Market Cap Rankings